Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine

Human infections with H7N9 avian influenza A virus can result in severe diseases with high mortality. Developing an effective vaccine is urgently needed to prevent its pandemic potential. Vaccine delivery routes via mucosal surfaces are known to elicit mucosal immune responses such as secretory IgA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Vaccines (Basel)
Asıl Yazarlar: Chen, Ting-Hsuan, Chen, Chung-Chu, Huang, Ming-Hsi, Huang, Chung-Hsiung, Jan, Jia-Tsrong, Wu, Suh-Chin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7349964/
https://ncbi.nlm.nih.gov/pubmed/32455704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8020240
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller